Huntsman Ronald Kirk has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 315421 shares of Vivos Therapeutics, Inc. ($VVOS) on November 26, 2024.
Activity breakdown: 5 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 26, 2024 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | A | Stock Option (Right to Buy) | 315421 | $2.64 | 364,755.0000 | 1,833,877 | 639.36% | 17.20% |
| June 20, 2024 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | A | Stock Option (Right to Buy) | 20000 | $2.38 | 49,334.0000 | 1,833,877 | 68.18% | 1.09% |
| June 20, 2023 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 14000 | $0.53 | 1,826,521.0000 | 0 | 0.77% | 0.00% |
| June 15, 2023 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 21 | $0.50 | 1,797,521.0000 | 0 | 0.00% | 0.00% |
| June 16, 2023 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 10000 | $0.54 | 1,807,521.0000 | 0 | 0.56% | 0.00% |
| June 16, 2023 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 5000 | $0.53 | 1,812,521.0000 | 0 | 0.28% | 0.00% |
| June 14, 2023 | Vivos Therapeutics, Inc. | $VVOS | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 10000 | $0.49 | 1,797,500.0000 | 0 | 0.56% | 0.00% |